Literature DB >> 17650026

Willingness-to-pay for schistosomiasis-related health outcomes in Kenya.

J M Kirigia1, L G Sambo, L H Kainyu.   

Abstract

Cost-benefit analysis (CBA) provides a framework for identifying, quantifying, and valuing in monetary terms all the important costs and consequences to society of competing disease interventions. Thus, CBA requires that impacts of schistosomiasis interventions on beneficiaries'health be valued in monetary terms Economic theory requires the use of the willingness to pay (WTP) approach in valuation of changes in health as a result of intervention. It is the only approach which is consistent with the potential Pareto improvement principle, and hence, consistent with CBA. The present study developed a health outcome measure and tested its operational feasibility. Contingent valuation for certain return to normal health from various health states, and for remaining in one's current health state were elicited through direct interview of randomly selected rice farmers, teachers, and health personnel in Kenya. The WTP to avoid risk of advancing to the next more severe state, seemed to be higher than WTP for a return to normal health. Generally, there was a significant difference between the average WTP values of farmers, teachers and health personnel populations. The gender and occupation variable coefficients were positive and highly significant in all regressions. The coefficients of the other explanatory variables were generally not statistically significant, indicating that medical expenses, anxiety cost, loss of earnings, and loss of work time, implied in various health states descriptions did not have significant effect on respondents expressed WTP values. The latter finding shows that there is need for more research to identify the other (besides gender and occupation) determinants of expressed WTP values in Africa. This study has demonstrated that it is possible to elicit coherent WTP values from economically under-developed countries. Further empirical work is clearly needed to at least address the validity and reliability of the contingent valuation approach and its measurements in Africa.

Entities:  

Year:  2000        PMID: 17650026

Source DB:  PubMed          Journal:  Afr J Health Sci        ISSN: 1022-9272


  5 in total

1.  Economic burden of cholera in the WHO African region.

Authors:  Joses M Kirigia; Luis G Sambo; Allarangar Yokouide; Edoh Soumbey-Alley; Lenity K Muthuri; Doris G Kirigia
Journal:  BMC Int Health Hum Rights       Date:  2009-04-30

2.  Economic burden of diabetes mellitus in the WHO African region.

Authors:  Joses M Kirigia; Hama B Sambo; Luis G Sambo; Saidou P Barry
Journal:  BMC Int Health Hum Rights       Date:  2009-03-31

3.  Cost of mental and behavioural disorders in Kenya.

Authors:  Joses M Kirigia; Luis G Sambo
Journal:  Ann Gen Hosp Psychiatry       Date:  2003-07-10

4.  Impact of disaster-related mortality on gross domestic product in the WHO African Region.

Authors:  Joses M Kirigia; Luis G Sambo; William Aldis; Germano M Mwabu
Journal:  BMC Emerg Med       Date:  2004-03-15

5.  Indirect cost of maternal deaths in the WHO African Region in 2010.

Authors:  Joses Muthuri Kirigia; Germano Mwige Mwabu; Juliet Nabyonga Orem; Rosenabi Deborah Karimi Muthuri
Journal:  BMC Pregnancy Childbirth       Date:  2014-08-31       Impact factor: 3.007

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.